Fresenius Medical Care AG (NYSE:FMS) Q2 2024 Earnings Call July 30, 2024 8:00 AM ET

Company Participants

Dominik Heger - Head, Investor Relations
Helen Giza - Chief Executive Officer and Chair
Martin Fischer - Chief Financial Officer

Conference Call Participants

Veronika Dubajova - Citi
Richard Felton - Goldman Sachs
Graham Doyle - UBS
Hassan Al-Wakeel - Barclays
Victoria Lambert - Berenberg
Hugo Solvet - BNP Paribas
James Vane-Tempest - Jefferies
David Adlington - JPMorgan
Falko Friedrichs - Deutsche Bank
Robert Davies - Morgan Stanley
Marianne Bulot - Bank of America

Dominik Heger

Thank you, Alice. Good morning, good afternoon or good evening, depending on where you are. I would like to welcome you to our earnings call for the second quarter of this year. We appreciate you joining us today.

As always, I do start out the call by mentioning our cautionary language that is in our Safe Harbor statement as well as in our presentation and in all the materials that we have distributed earlier today. For further details concerning risks and uncertainties, please refer to these documents as well as to our SEC filings. The call is scheduled for 60 minutes. We have prepared a presentation and we’ll have time for your questions after the prepared remarks. As always, we would like to limit the number of questions to two in order to give everyone the chance to ask. In case there are further questions and time left, we will gladly offer a second round.

Let me now welcome Helen Giza, our CEO and Chair of the Management Board; and Martin Fischer, our CFO. Helen will begin the presentation with an update on the major developments and Martin will provide a review of the financial performance in the second quarter. Afterwards, we are happy to take your questions.

With that, Helen, the floor is yours.

Helen Giza

Thank you, Dominik. Welcome, everyone. Thank you for joining our presentation today and for your continued interest in Fresenius Medical Care.

I will begin my prepared remarks on Slide 4. We continue to deliver on our commitments while executing against our strategic plan and working through the company transformation and turnaround efforts. I am proud of the progress we are making in realizing improved financial performance and progress towards our 2025 group margin target. While there is clearly more work to be done and external factors to address, overall, we have made important progress to strengthen our business and position ourselves for sustainable profitable growth over the medium and long term. None of that would be possible without each and every one of our employees around the globe, for which they have most gratitude.